Virus News and Research

Latest Virus News and Research

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

COVID-19-related hospitalization among infants and young children in the US

COVID-19-related hospitalization among infants and young children in the US

Researchers argue that Omicron's lower severity is a coincidence

Researchers argue that Omicron's lower severity is a coincidence

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

Study finds high rates of cancer among men living with HIV

Study finds high rates of cancer among men living with HIV

Impact of new COVID vaccinations as novel variants emerge

Impact of new COVID vaccinations as novel variants emerge

Research demonstrates within-host seasonal immunity

Research demonstrates within-host seasonal immunity

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Novel screening method detects new N501T SARS-CoV-2 variant

Novel screening method detects new N501T SARS-CoV-2 variant

Huddersfield researchers demonstrate how coronavirus activates the brain's immune response

Huddersfield researchers demonstrate how coronavirus activates the brain's immune response

Study finds extensive harassment of public health officials during first 11 months of the pandemic

Study finds extensive harassment of public health officials during first 11 months of the pandemic

Two clever human antibodies can target Ebola and Sudan virus

Two clever human antibodies can target Ebola and Sudan virus

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Narrative review reports two important mediators in SARS-CoV-2-induced ischemic stroke recovery

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.